Pfizer Inc
NYSE: PFE
$26.72
-$0.14 (-0.5%)
Closing Price on January 10, 2025
PFE Articles
Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year to date, Its shares are up 11%.
Published:
Last Updated:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockJanuary 13, 2015: Markets opened higher again...
Published:
Last Updated:
One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night and day different from the Pfizer of 2005.
Published:
One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have upside performance above what was expected.
Published:
thinkstockDecember 26, 2014: Markets opened higher on Friday on a morning when it was difficult to find any market-moving news at all. Energy opened higher but traded about $1 a barrel lower (down...
Published:
Last Updated:
With investors loving dividends so much, 24/7 always tries to take a look at what the Dogs of the Dow will look like for the year ahead.
Published:
While this was generally a known event coming down the pipe, arthritis drug Celebrex now has a generic competitor in America.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockDecember 4, 2014: Markets opened higher on...
Published:
Last Updated:
The U.S. equity market is still a great place to be, and the analysts at Jefferies may have a good plan for where to rotate some 2014 winners and losers.
Published:
A new report from Jefferies focuses on four stocks to buy that have impending events that could make a difference for investors.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockNovember 25, 2014: Markets opened higher on...
Published:
Last Updated:
For the third consecutive year, the company spending the most on research and development (R&D) was Germany's Volkswagen.
Published:
Last Updated:
Durect and Pain Therapeutics have been stung by Pfizer's decision to discontinue to develop Remoxy.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. thinkstockOctober 24, 2014: Markets opened slightly...
Published:
Last Updated:
Pfizer's new buyback is simply too large and too significant to ignore, and it might jokingly be called "on Viagra."
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.